Evidence map›Paper›PMID 31023263›Full record

ArticleBMC cancer2019

Clinicopathological characteristics and health care for Tibetan women with breast cancer: a cross-sectional survey.

Yulan Zhao, Hanhuan Luo, Xintian Zhang, Tashi Bianba, Lin Li, Qian Wang, Lei Guo, Dian Wang, Yongge Ze, Shan Zheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yulan ZhaoDepartment of Oncology, Tibet autonomous region people's hospital, autonomous region, Lhasa, 850000, Tibet, China.
Hanhuan LuoDepartment of Pathology, Tibet autonomous region people's hospital, autonomous region, Lhasa, 850000, Tibet, China.
Xintian ZhangDepartment of Second Clinical Medicine, Sun Yat-sen University Zhongshan School of Medicine, Yuexiu District, Guangzhou, 510080, Guangdong, China.
Tashi BianbaDepartment of Oncology, Tibet autonomous region people's hospital, autonomous region, Lhasa, 850000, Tibet, China.
Lin LiDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and PeKing Union Medical College, Beijing, 100021, China.
Qian WangDepartment of Pathology, Tibet autonomous region people's hospital, autonomous region, Lhasa, 850000, Tibet, China.
Lei GuoDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and PeKing Union Medical College, Beijing, 100021, China.
Dian WangDepartment of Imaging, Tibet autonomous region people's hospital, autonomous region, 850000, Tibet, China.
Yongge ZeDepartment of Oncology, Tibet autonomous region people's hospital, autonomous region, Lhasa, 850000, Tibet, China. zyg13989999353@sina.com.
Shan ZhengDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and PeKing Union Medical College, Beijing, 100021, China. zhengshan@cicams.ac.cn.ORCID http://orcid.org/0000-0001-8220-3626

Funding

Chinese Academy of Medical Sciences Initiative for Innovative Medicine 2016-I2M-1-001Natural Science Foundation of Tibet Autonomous Region 2015ZR-13-61
6 · The paper itself

Abstract

backgroundThe healthcare system (HCS) improved in Tibet Autonomous Region (TAR), China. The present study aimed to investigate whether these improvements might alter the clinicopathological characteristics of a Tibetan female with breast cancer (BC) in TAR.

methodsThis was a single-center cross-sectional study conducted at TAR People's Hospital. All Tibetan adult women were treated for BC in this hospital between January 1, 1973 and December 31, 2015. The inclusion criteria were as follows: (1) Tibetan adult woman living in Tibet; (2) Histopathology or cytopathology or both confirming primary BC; (3) All the treatments were finished in this hospital. χ

resultsA total of 273 patients with BC were included in the final analysis. Of these, 14 patients were in the free HCS, 183 patients had medical insurance combined with a new rural cooperative HCS, and 76 were in a rural and urban integration HCS. Currently, a rural and urban integration HCS is an improved system. Consequently, an increase in the proportion patients in the T1-3 stage was observed (0.198; 0.046 to 0.852) between the rural and urban integration HCS and free HCS. The proportion of patients in early (I + II) stage cancer (0.110; 0.019-0.633) also increased between these two HCSs.

conclusionThis was the first report about Tibetan women with BC in Tibet. Some clinicopathological characteristics at the presentation of Tibetan women with BC may improve during different HCSs. The cancer awareness, early detection, and the overall management in patients with advanced stage BC might improve the prognosis of BC in the rural and urban integration HCS.

Indexed as

Delivery of Health CareEarly Detection of CancerAdultAgedBreast NeoplasmsChinaCross-Sectional StudiesFemaleHumansMiddle AgedPrognosisRural PopulationSurveys and QuestionnairesTibetUrban PopulationBreast cancerClinicopathological characteristicsHealthcare systemPlateauTibetan female

Identifiers

PMID31023263
PMCPMC6482490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.